Healthcare & Pharma • Quantitative Market Data & AI Analytics
| Metric / Indicator | Current Reading | AI Action Verdict |
|---|---|---|
| RSI (14) Relative Strength | 48.35 | 🔒 Unlock AI Verdict |
| MACD (12, 26, 9) Level / Signal | -50.44 / -13.39 | 🔒 Unlock AI Verdict |
| Bollinger Bands (20, 2) & EMA (50/200) | 11,577.60 - 12,542.40 | BULLISH TREND |
| AI News Sentiment & Momentum Score | 82.5 / 100 | High Accumulation |
| AI Hybrid Probability & 30D Target Range | 11,336.40 - 13,507.20 | STRONG BUY |
You are viewing raw mathematical RSI (48.4) and MACD (-50.44) computations. To unlock AI interpretation, Bullish/Bearish ratings, Bollinger Bands, Executive Insider Trades, and 30-Day Statistical Trend Charts for AstraZeneca, download the TradeGPT Android app.
Download on Google Play
AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biotechnology company that is a global leader in biopharmaceutical innovation. The company's primary focus lies in three core therapy areas: Oncology, Rare Diseases (strengthened by the acquisition of Alexion), and BioPharmaceuticals (comprising Cardiovascular, Renal & Metabolism, and Respiratory & Immunology). AstraZeneca is renowned for its robust R&D pipeline and its commitment to precision medicine and data-driven drug discovery. A major player in global health, the company maintains extensive manufacturing facilities and research centers worldwide, focusing on life-changing medicines that address complex unmet medical needs. Its corporate headquarters are located in Cambridge, United Kingdom.
Read more Google Play
